Vanguard Fiduciary Trust
ALDX icon

Vanguard Fiduciary Trust’s Aldeyra Therapeutics ALDX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
298,242
-40,379
-12% -$69.4K ﹤0.01% 3193
2026
Q1 		$572K Buy
+338,621
New +$1.48M ﹤0.01% 3171

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Fiduciary Trust's ALDX Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Aldeyra Therapeutics (ALDX) stake by 12% in Q2 2026, selling an estimated $69.4K and leaving 298,242 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Vanguard Fiduciary Trust first reported a position in ALDX in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Vanguard Fiduciary Trust held 298,242 shares of Aldeyra Therapeutics worth $635K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 40,379 Aldeyra Therapeutics shares in Q2 2026, an estimated $69.4K.
  • Aldeyra Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3193 holding.
  • Vanguard Fiduciary Trust first reported a position in Aldeyra Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.